W
Winnie Yeo
Researcher at The Chinese University of Hong Kong
Publications - 291
Citations - 19511
Winnie Yeo is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 60, co-authored 282 publications receiving 16440 citations. Previous affiliations of Winnie Yeo include University of Hong Kong.
Papers
More filters
Journal ArticleDOI
Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.
Simon C.H. Yu,Stephen L. Chan,Kit Fai Lee,Joyce W.Y. Hui,Edwin P. Hui,Cheuk Man Chu,Anthony W.H. Chan,Sunny Y.S. Cheung,Leung Li,John Wong,Winnie Yeo +10 more
TL;DR: ACE is a feasible, safe, and well-tolerated treatment for patients with HCC; it is highly effective and may be more effective than cTACE in achieving CR and the complete response rates by patient or by tumor were both 100%.
Journal ArticleDOI
A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer
Tony Mok,Thomas W.T. Leung,Gill Brown,Chris Moyses,Anthony T.C. Chan,Winnie Yeo,Herman Wong,Karen Chak,Philip J. Johnson +8 more
TL;DR: Elimination half-life of OGT 719 by 3-h intravenous infusion is short and monophasic, and Toxicity was minimal at the highest dose level.
Journal ArticleDOI
Profile of mood states and quality of life of Chinese postmastectomy women in Hong Kong: Integrating variable- and person-centered approaches
Kristina Shin,Fraide A. Ganotice,Kevin Downing,Lee Wai Yip,Fred Han,Winnie Yeo,Joyce J. S. Suen,Kun M. Lee,Simone S M Ho,Sung Inda Soong,Ka Yan Wong,Carol Kwok,Kaoru Leung +12 more
TL;DR: The complementary strengths of the application of both variable- and person-centered approaches were extended to clarify relationships and to identify profiles of mood states in relation to QOL in a sample of 200 women who had undergone a mastectomy in Hong Kong.
Journal Article
Imatinib-induced interstitial lung disease and sunitinib-associated intra-tumour haemorrhage
Herbert H. Loong,Winnie Yeo +1 more
TL;DR: An ethnically Chinese patient with newly diagnosed metastatic gastro-intestinal stromal tumour initially treated with imatinib mesylate developed severe interstitial lung disease and was started on sunitinib malate, a case report illustrates the dilemmas and complexities associated with treating patients with gastro- gastrointestinal stroma with the new tyrosine kinase inhibitors.
Journal ArticleDOI
Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC)
Josep M. Llovet,Philippe Merle,Karl Heinz Weiss,Thomas Yau,Paul Ross,Vincenzo Mazzaferro,Jean-Frédéric Blanc,Yuk Ting Ma,Chia Jui Yen,Judit Kocsis,Su Pin Choo,Watana Sukeepaisarnjaroen,René Gerolami,Jean-François Dufour,Edward Gane,Baek-Yeol Ryoo,Markus Peck-Radosavljevic,Thong Dao,Winnie Yeo,Wisut Lamlertthon,Satawat Thongsawat,Michael Teufel,Heiko Krissel,Ho Yeong Lim +23 more